BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
+1.1%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$101M
AUM Growth
+$101M
(-13%)
Cap. Flow
+$2.26M
Cap. Flow
% of AUM
2.25%
Top 10 Holdings %
Top 10 Hldgs %
56.77%
Holding
80
New
12
Increased
15
Reduced
13
Closed
9
Top Buys
| 1 |
KLA
KLAC
|
$14.2M |
| 2 |
Ovintiv
OVV
|
$2.1M |
| 3 |
NovoCure
NVCR
|
$1.25M |
| 4 |
Freeport-McMoran
FCX
|
$782K |
| 5 |
Structure Therapeutics
GPCR
|
$747K |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$16.7M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$1.63M |
| 3 |
United Therapeutics
UTHR
|
$934K |
| 4 |
Travere Therapeutics
TVTX
|
$518K |
| 5 |
Masimo
MASI
|
$505K |
Sector Composition
| 1 | Healthcare | 79.06% |
| 2 | Technology | 14.1% |
| 3 | Energy | 6.07% |
| 4 | Materials | 0.78% |
